RJA
MRK icon

Ross\Johnson & Associates’s Merck MRK Stock Holding History

Ross\Johnson & Associates’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.73K Buy
29
+5
+21% +$585 0.06% 61
2026
Q1 		$2.89K Sell
24
-3
-11% -$346 0.05% 63
2025
Q4 		$2.84K Sell
27
-21
-44% -$1.97K 0.05% 63
2025
Q3 		$4.03K Buy
48
+24
+100% +$1.98K 0.08% 54
2025
Q2 		$1.9K Sell
24
-617
-96% -$49K 0.04% 66
2025
Q1 		$57.5K Buy
641
+18
+3% +$1.68K 0.99% 15
2024
Q4 		$62K Buy
+623
New +$64.2K 1.43% 8

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ross\Johnson & Associates's MRK Position: Q2 2026 in Review

Ross\Johnson & Associates increased its Merck (MRK) stake by 21% in Q2 2026, buying an estimated $585 and bringing the position to 29 shares worth $3.73K. The position accounts for 0.06% of the portfolio, ranked #61.

Ross\Johnson & Associates first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $62K in Q4 2024. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Ross\Johnson & Associates held 29 shares of Merck worth $3.73K as of Q2 2026.
  • Ross\Johnson & Associates bought 5 Merck shares in Q2 2026, an estimated $585.
  • Merck made up 0.06% of Ross\Johnson & Associates's portfolio in Q2 2026, its #61 holding.
  • Ross\Johnson & Associates first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • Ross\Johnson & Associates's Merck position peaked at $62K in Q4 2024.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Ross\Johnson & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.